APPLICATIONS PUBLISHED 23 OCTOBER 2002
Published: 1-Apr-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Pharmaceutical compsns comprising terbinafine
Novartis 1250125*
Transepithelial delivery of GLP-1 derivatives
Novo Nordisk 1250126*
A method of administering a medicinal aerosol formulation
Aeropharm Technology 1250127*
Inhibitors of adeonsine kinase for the treatment of the optic nerve and retinal damage
Alcon 1250128*
Methods to treat (a)-1-antitrypsin deficiency
Washington University 1250129*
Propofol formulation with enhanced microbial inhibition
Amphastar Pharmaceuticals 1250130*
Modulation of the blood-brain barrier transportation for leptin
The Administrators of the Tulane University Educational Fund 1250131*
Ibuprofen-containing active agent preparation
BASF 1250132*
Ophthalmic anti-allergy compsn suitable for use with contact lenses
Alcon Universal 1250133*
Compsns for the prevention of diaper dermatitis
Mentis Technology 1250134*
O-methylated rapamycin derivatives for alleviation and treatment of lymphoproliferative disorders
The Trustees of the University of Pennsylvania 1250135*
Methods for the treatment of substance abuse
Shulman, Albert 1250136*
JAK/STAT pathway inhibitors and the uses thereof
Genzyme 1250137*
Fulvestrant formulation
AstraZeneca 1250138*
Product for treating gynecomastia
Pharmacia Italia 1250139*
Combinations of a receptor tyrosine kinase inhibitor with alpha1-acidic glycoprotein binding compound
Novartis 1250140*
Prevention and treatment of endotoxemia and related complications associated with surgery
Eisai 1250141*
Multivalent electron active compsns and methods of making and using same
Marantech Holding 1250142*
Reduction in bacterial colonisation by administering bacteriophage compsns
Intralytix 1250143*
Vegetable oil for preparing a compsn inhibiting 5(a)-reductase activity
Laboratoires Pharmscience 1250144*
C-Ski oncogene-derived peptides for prevention, treatment and diagnosis of cancer
Argonex Pharmaceuticals 1250145*
Use of neurotoxins for treating diabetes
Allergan Sales 1250146*
Interferon-alpha use in the treatment of Ewing's family of tumours
Institut National de la Sante et de la Recherche Medicale 1250147*
Use of FSH for treating infertility
Applied Research Systems 1250148*
A novel method for diagnosing, monitoring, staging, imaging and treating cancer
Diadexus 1250149*
Innate immunity-stimulating compsns of CPG and saponin and methods thereof
Antigenics 1250150*
Compsn consisting of an active ingredient and a therapeutically active delivery system, especially in the treatment of angiogenesis
Theryte 1250151*
Hyaluronic acid in the treatment of cancer
Bioniche Life Sciences 1250152*
Treatment of I C. difficile/1 toxin B associated conditions
Synsorb 1250153*
G-CSF conjugates
Maxygen Holdings 1250154*
Angiogenesis and vascular permeability modulators and inhibitors
The Scripps Research Institute 1250155*
Method for nucleic acid transfection of cells
Genteric 1250156*
Antisense modulation of inducible nitric oxide synthase expression
Isis Pharmaceuticals 1250157*
Hyperpolarisation of a gas
Oxford Instruments Superconductivity 1250158*
High pressure sterilising of sensitive active principles
Ellipse Pharmaceuticals 1250159*
Antimicrobial flash-dry disinfectant aerosol
Triosyn Holding 1250160*
Polymer blends as biodegradable matrices for preparing biocomposites
Intralytix 1250161*
Organic resorbable bone substitute material and production method
Dot Duennschicht-und Oberflaechentechnologie 1250163*
Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia
Edwards Lifesciences Corp 1250166*
Method for producing N-alkoxy-N-alkylamides
Lonza 1250316*
Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
Boehringer Ingelheim 1250317*
Method for producing aryl-iminomethyl-carbamic acid esters
Boehringer Ingelheim Pharma 1250318*
Novel process for the preparation of alpha-(2,4-disulphophenyl)-N-tert-butyronitrone and pharmaceutically acceptable salts thereof
AstraZeneca 1250320*
Glyburide compsn
Bristol-Myers Squibb 1250321*
Compounds having hypolipidemic and hypocholesterolemic activities, process for their preparation and pharmaceutical compsns containing them
Cadila Healthcare 1250323*
Biaryl compounds, their preparation and their uses in therapy
RiboTargets 1250324*
Phenanthridine-N-oxides
Altana Pharma 1250325*
Indazole compounds, pharmaceutical compsns, and their use for mediating or inhibiting cell proliferation
Agouron Pharmaceuticals 1250326*
Process for producing N-halogenated organic compounds
Albemarle 1250327*
Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
Lipha 1250328*
Phenothiazines in prill form
Avecia 1250329*
Process for the preparation of 3-furoate esters and novel intermediate compounds
Eastman Chemical Company 1250330*
Formulation for protection against oxidative stress containing benzofuranone derivatives
Merck 1250331*
Inhibitors of interleukin 5 gene expression
Abbott Laboratories 1250332*
Dendrimer precursor dyes for imaging
Mallinckrodt 1250333*
Agents and methods for the treatment of proliferative diseases
Eli Lilly 1250334*
Process and intermediates for the preparation of imidazopyridines
Altana Pharma 1250335*
Piperidine derivatives and their use as serotonin receptor antagonists
Eli Lilly 1250336*
Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
Janssen Pharmaceutica 1250337*
Pyrazano-pyridazine derivatives as ligands for GABA receptors
Merck Sharp & Dohme 1250338*
Porphyrins and related compounds
Scotia Holdings 1250339*
Methods and compounds for inhibiting MRP1
Eli Lilly 1250340*
A method of generating a functionalised arylphosphine
The University of Liverpool 1250341*
Azalide antibiotic compsns
Pfizer Products 1250343*
Compound comprising a nucleic acid and an organo-silane moiety
VBC-Genomics Bioscience Research 1250344*
Methods and materials relating to G protein-coupled receptor-like polypeptides and polynucleotides
Hyseq 1250346*
Antisense modulation of AKT-3 expression
Asis Pharmaceuticals; Leland Stanford Junior University 1250347*
Cardiac-cell specific enhancer elements and uses thereof
Beth Israel Deaconess Medical Center 1250349*
Novel crystalline composites comprising phytosterols and phytostanols or derivatives thereof
Forbes Medi-Tech 1250350*
Methods to identify CTL epitopes of HIV
Statens Serum Institut 1250351*
Receptor-like protein kinases from Nicotinia tabacum
Bayer 1250352*
P21 derived peptides capable of inhibiting CDK/cyclin complexes
Cyclacel 1250353*
Peptide fragments of colostrinin and their use
Regen Therapeutics 1250354*
Chimeric prostate-homing peptides with pro-apoptotic activity
The Burnham Institute 1250355*
Potassium channel mutants of the I Saccharomyces cerevisiae/I yeast and the use thereof for screening of eukaryotic potassium channels
Aventis Pharma Deutschland 1250356*
Myostatin and mimetics thereof
Agresearch 1250357*
Therapeutic peptides
Pharma Pacific 1250358*
Chitosan condensation products, their preparation and their uses
BTG International 1250359*
